Table 2.
ICER of related HSCT compared to BT-ICT, classified by patient age
| Age (year) | Incremental cost | Incremental QALY | ICERs of related HSCT compared to BT-ICT |
|---|---|---|---|
| million THB | QALY gained | THB per QALY gained* | |
| 1 | 0.81 | 10.00 | 80,700 |
| 5 | 0.78 | 8.96 | 86,800 |
| 10 | 0.72 | 7.02 | 103,000 |
| 15 | 0.61 | 3.32 | 183,000 |
| 17 | 0.55 | 2.14 | 257,000 |
| 18 | 0.55 | 1.78 | 308,000 |
| 19 | 0.48 | 0.84 | 574,000 |
| 20 | 0.40 | -0.20 | Dominated§ |
| 25 | 0.30 | -2.05 | Dominated§ |
| 28 | 0.31 | -2.17 | Dominated§ |
ICER: incremental cost-effectiveness ratio; HSCT: hematopoietic stem cell transplantation; BT-ICT: blood transfusion combined with subcutaneous iron chelating therapy; THB: Thai baht (in 2008 value); and QALY: quality adjusted life year.
*ICERs are rounded up to nearest 1,000 THB.
§Negative ICER due to higher effectiveness and lower costs of BT-ICT compared with HSCT.